AdaptHealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AdaptHealth Corp reports robust revenue growth and strategic investments outlook

AdaptHealth Corp demonstrated resilience in revenue growth despite challenges, with a strong focus on patient care and financial performance. While facing short-term obstacles, the company is strategically positioned to capitalize on growth opportunities and improve margins through cost-cutting measures.

AdaptHealth Corp reports revenue growth amidst diabetes business challenges

AdaptHealth Corp's Q1 2023 performance showed revenue growth but faced challenges in the diabetes business, prompting cost-saving measures.
Despite hurdles, the company remains confident in its strategy, focusing on growth opportunities and operational efficiency to drive performance.
Management's proactive approach to cost reduction and revenue enhancement positions AdaptHealth well for future growth and financial stability.

AdaptHealth Corp posts solid Q2 results, eyes growth opportunities

AdaptHealth Corp's Q2 performance reflects strong revenue growth and improved EBITDA, driven by key product lines.
While challenges exist in the diabetes segment, the company is focused on operational enhancements and cost-saving measures.
Opportunities for growth and efficiency improvements are present, with a commitment to executing strategies and leveraging expertise.
Management's emphasis on financial processes and operational efficiency bodes well for future performance and market positioning.

AdaptHealth Corp reports record revenues, faces EBITDA challenges, eyes growth

AdaptHealth Corp's Q3 performance reflects revenue growth driven by the sleep business, with a focus on enhancing patient experience. Challenges include EBITDA shortfall due to contract delays and impairment to goodwill. The company is seizing opportunities in CGM data utilization and diversification strategies for growth.
With a strong emphasis on patient care and operational efficiency, AdaptHealth Corp is navigating challenges in revenue decline and tough comps, aiming for sustained growth. The company's strategic focus on market penetration and patient outcomes positions them for future success.

AdaptHealth Corp excels in Q4 2023, eyes growth opportunities

AdaptHealth Corp's strong performance in Q4 2023 and full-year highlights organic growth.
Challenges from GLP-1 drugs and government exposure are being addressed proactively.
Opportunities lie in projected revenue growth, market share improvement, and cost reduction.
Overall, AdaptHealth is well-positioned for continued growth and market resilience.

AdaptHealth Corp excels in Q1 2024, eyes growth and debt reduction

AdaptHealth Corp's Q1 2024 performance reflects solid financial growth, operational improvements, and strategic initiatives aimed at enhancing profitability and market position.
While challenges like managing potential risks in key segments and addressing debt obligations exist, the company's strengths in leadership, revenue diversification, and cost management provide a strong foundation for future success.
By capitalizing on growth opportunities in key business segments and markets, AdaptHealth Corp is well-positioned to achieve its financial targets, drive sustainable growth, and enhance shareholder value.

AdaptHealth Corp reports solid Q2 results and raises full-year guidance

AdaptHealth Corp's Q2 performance met expectations with a strong focus on driving growth through investments and operational improvements. Despite challenges in certain revenue segments, the company remains optimistic about future prospects.

AdaptHealth Corp reports solid Q3 performance amid operational enhancements

AdaptHealth Corp's Q3 results reflect resilience and strategic initiatives to drive growth amidst operational challenges.
The company's proactive measures to address issues in the diabetes segment and optimize other product lines position it for future success.
With a strengthened financial position and a focus on operational efficiency, AdaptHealth is poised for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) common stock: (1) between August 4, 2020 and February 27, 2023, inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to the Company's January 2021 secondary public offering (the “SPO”).

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of AdaptHealth Corp. (AHCO) Investors

AdaptHealth Corp. (NASDAQ:AHCO ) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Richard Barasch - Interim Chief Executive Officer Jason Clemens - Chief Financial Officer Conference Call Participants Matthew Blackman - Stifel Pito Chickering - Deutsche Bank Richard Close - Canaccord Genuity Joanna Gajuk - Bank of America Eric Coldwell - Baird Operator Good day, everyone, and welcome to today's AdaptHealth Third Quarter 2023 Earnings Release Call. At this time, all participants are in a listen-only mode.

AdaptHealth Corp. (AHCO) Q3 2023 Earnings Call Transcript

LOS ANGELES, CA / ACCESSWIRE / November 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AdaptHealth Corp. ("AdaptHealth" or "the Company") (NASDAQ:AHCO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 4, 2020 and February 27, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 23, 2023.

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses of $100,000 to Contact the Firm

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) common stock: (1) between August 4, 2020 and February 27, 2023, inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to the Company's January 2021 secondary public offering (the “SPO”). AdaptHealth investors have until December 26, 2023 to file a lead plaintiff mo.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of AdaptHealth Corp. (AHCO) Investors

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2023. Third Quarter Results and Highlights All comparisons are to the quarter ended September 30, 2022 unless otherwise stated. Net revenue was $804.0 million compa.

AdaptHealth Corp. Announces Third Quarter 2023 Results

SAN DIEGO--(BUSINESS WIRE)---- $AHCO #AdaptHealthCorp--AdaptHealth Corp. (AHCO) Misrepresented the Success and Growth of its Diabetes Segment.

AdaptHealth Corp. (AHCO) Shareholders with Significant Losses Should Contact Robbins LLP for Information about the AdaptHealth Corp. Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your AdaptHealth investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securi.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AdaptHealth Corp. (AHCO) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) investors concerning the Company's possible violations of federal securities laws. On February 27, 2023, AdaptHealth announced a loss of $0.02 per share for the fourth quarter of 2022, significantly less than the gain of $0.27 per share that analysts and investors had expected. The Company also reduced its 2023 guidance, lowerin.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AdaptHealth Corp. (AHCO) on Behalf of Investors

NEW YORK , Nov. 4, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the "Class Period") or (2) AdaptHealth common stock pursuant and/or traceable to the Company's secondary public offering (the "SPO") conducted on or around January 5, 2021. A class action lawsuit has already been filed.

NATIONALLY RANKED ROSEN LAW FIRM Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AHCO

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On February 27, 2023, AdaptHealth announced a loss of $0.02 per share for the fourth quarter of 2022, significantly less than the gain of $0.27 per share that analysts and.

The Law Offices of Frank R. Cruz Announces Investigation of AdaptHealth Corp. (AHCO) on Behalf of Investors

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the “Class Period”) or (2) AdaptHealth common stock pursuant and/or traceable to the Company's secondary public offering (the “SPO”) conducted on or around January 5, 2021. A class action lawsuit has already been filed. I.

EQUITY ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AHCO

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons and entities who purchased or otherwise acquired AdaptHealth securities common stock between August 4, 2020 and February 27, 2023, inclusive (the “Class Peri.

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against AdaptHealth Corp. and Encourages Investors to Contact the Firm

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 26, 2023 to file lead plaintiff applications in a securities class action lawsuit against AdaptHealth Corp. (NasdaqCM: AHCO), if they purchased or otherwise acquired the Company's shares (i) between August 4, 2020 and February 27, 2023, inclusive (the “Class Period”); and/or (ii) pursuant and/or traceable to.

ADAPTHEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AdaptHealth Corp. - AHCO

NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action lawsuit in the U.S. District Court for the Eastern District of Pennsylvania alleging violations of the federal securities laws by AdaptHealth Corp. (“AdaptHealth” or the “Company”), certain of the Company's current and former senior executives and directors, and certain underwriters of the Company's secondary public offering conducted on or around.

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AdaptHealth Corp.

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2023 financial results before the opening of the financial markets on Tuesday, November 7, 2023. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analys.

AdaptHealth Corp. Announces Third Quarter 2023 Earnings Release Date and Conference Call

AdaptHealth said on Wednesday the company and recently appointed CEO Crispin Teufel mutually agreed to terminate Teufel's employment contract.

AdaptHealth says terminated appointment contract for incoming CEO

AdaptHealth's partnership with Humana is expected to drive future growth by expanding the customer base and focusing on value-based care. Its diabetes segment is recovering, with growth in Continuous Glucose Monitoring outweighing pump challenges. AHCO reported impressive second quarter results, with year-over-year revenue growth of 9% and improved EBITDA margin.

AdaptHealth: Growth Prospects And CEO Appointment Brings Opportunities Amid Legal Matters

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Richard Barasch, Chairman and interim CEO, and Josh Parnes, President, will participate in Baird's 2023 Global Healthcare Conference, being held in New York, on Tuesday, September 12, 2023, including a presentation at 9.

AdaptHealth Corp. to Participate in Baird's 2023 Global Healthcare Conference

AdaptHealth named Crispin Teufel as its next CEO in June, with an expected start date of Sept. 1. Teufel is now being sued by his former employer, Linde, to prevent him from going to AdaptHealth, to protect confidential trade secrets.

Why AdaptHealth Stock Dropped Today

U.S. respiratory equipment provider AdaptHealth said on Thursday its incoming CEO Crispin Teufel has been sued by former employer Linde , and is seeking to block the appointment for an unspecified time.

AdaptHealth says incoming CEO sued by former employer Linde

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.18 per share a year ago.

AdaptHealth Corp. (AHCO) Q2 Earnings and Revenues Top Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. Net revenue was $793.3 million compared to $.

AdaptHealth Corp. Announces Second Quarter 2023 Results

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Richard Barasch, Chairman and interim CEO, Josh Parnes, President, and Jason Clemens, CFO, will participate in the Canaccord Genuity 43rd Annual Growth Conference, being held in Boston, on Wednesday, August 9, 2023, inc.

AdaptHealth Corp. to Participate in the Canaccord Genuity 43rd Annual Growth Conference

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2023 financial results before the opening of the financial markets on Tuesday, August 8, 2023. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analyst.

AdaptHealth Corp. Announces Second Quarter 2023 Earnings Release Date and Conference Call

AdaptHealth Corp. (AHCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

News for AdaptHealth Corp Stock (AHCO)